In summary, these findings demonstrate that PreS1‐pHLIP NMs effectively accumulate at tumor sites and respond to the MMP2‐rich TME, releasing PreS1‐pHLIP and mediating its targeted insertion into tumor cell membranes via pHLIP. The gene discussed is MMP2; the disease is neoplasm.